Anavex Life Sciences Corp (AVXL)

[Investor2014]

Some here are repeatedly implying that Anavex will far from have the funds required for conducting the 3 trials announced to commence this year, and in particular not the AD P2/3.

I am suggesting that the several pre-clinical and the phase 1 and 2 clinical trials already conducted, could not have been funded in full either by Anavex alone, but instead by a majority of the cost being meet by external organisations. This should be as clear as alleged for new trails based upon dissecting past Anavex financial reports held up against guesstimates of trial costs.

Now, let's imagine Caulfield/Alfred Health are receiving funding, as they do, from government or other organisations in Australia or elsewhere to run trials. If so, then whatever grants that may go towards Anavex drug trials do not need to and will not appear in the accounts of Anavex.

Therefore, my argument remains that it is reasonable to expect that the majority of the funding required for the upcoming trials will not be funded by Anavex. However, the proportion of funds needed for the AD P2/3 trial in particular are such that Anavex is building up the required financial muscle to fund their part of trial activities through the LPC facility.